DeepFacts builds AI tools to monitor patients in real time

The details

• DeepFacts is a healthcare startup that builds AI tools to monitor patients in real time, especially in hospital wards and rooms.
• The company’s flagship product, proRITHM, is a wearable device that tracks key patient vitals such as heart rate, temperature, oxygen saturation, respiratory rate, and blood pressure.
• proRITHM sends this data in real time to a cloud-based dashboard, allowing doctors and nurses to monitor patients remotely and respond quickly to changes in condition.
• The device is designed to be worn on the chest and allows patients to move freely while still being monitored, reducing the need for frequent physical checks.
• proRITHM includes a feature that lets doctors set personalized thresholds for each patient, triggering alerts only when readings move outside those limits.
• The platform also calculates an early warning score to rate patient risk on a scale from one to seven, helping doctors intervene earlier if a patient’s condition worsens.
• proRITHM is classified as a medical-grade device under Class B and is CE self-certified, with the team working toward US FDA 510(k) clearance.

The bigger picture

• The problem DeepFacts is solving is the lack of continuous monitoring for patients outside the ICU, where checks are often done only every few hours.
• This delay in monitoring can put patients at serious risk if something goes wrong between checks.
• proRITHM helps reduce the gap between patients and doctors by providing real-time data and early warnings.
• The device is designed to be used in both private and public healthcare systems, addressing a global issue in quality of care and patient safety.

About the business

• DeepFacts focuses on improving patient care through real-time monitoring and early detection of health risks.
• The company’s product, proRITHM, is a wearable device that continuously tracks patient vitals and sends data to a cloud-based dashboard.
• The device is designed to be used in hospital wards and rooms, where monitoring is often less frequent than in ICUs.
• proRITHM includes features like personalized thresholds, early warning scores, and mobility support to enhance patient care and reduce infection risks.
• The company is working toward international regulatory approvals, including US FDA 510(k) clearance, to ensure its product meets global standards.

The deal

Type

funding

Founders

• Vamsi Karatam, founder

Same day

• Swiggy Instamart CEO says no to discount-driven growth29 January 2026 · Analysis
• Ayuvya fails to secure deal on Shark Tank India29 January 2026 · Analysis
• EarthSync raises $1M pre-seed round29 January 2026 · Funding · $1M
• Paytm reports first quarterly profit after years of losses29 January 2026 · Results · ₹225 Cr
• 1Buy.AI raises ₹32.5 crore to build AI operating system for electronics procurement29 January 2026 · Funding · Rs 32.5 crore ($3.9 million)
• Fino payments bank reports Q3 results and seeks RBI approval for conversion29 January 2026 · Results

All startup news on 29 January 2026 →